PLUR
Price
$4.86
Change
+$0.12 (+2.53%)
Updated
Aug 13, 11:23 AM (EDT)
Capitalization
37.31M
SNES
Price
$4.64
Change
+$0.05 (+1.09%)
Updated
Aug 13, 03:06 PM (EDT)
Capitalization
22.79M
Interact to see
Advertisement

PLUR vs SNES

Header iconPLUR vs SNES Comparison
Open Charts PLUR vs SNESBanner chart's image
Pluri
Price$4.86
Change+$0.12 (+2.53%)
Volume$301
Capitalization37.31M
SenesTech
Price$4.64
Change+$0.05 (+1.09%)
Volume$300
Capitalization22.79M
PLUR vs SNES Comparison Chart in %
Loading...
PLUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNES
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), IQVIA Holdings (NYSE:IQV), Biogen (NASDAQ:BIIB), Incyte Corp (NASDAQ:INCY), Illumina (NASDAQ:ILMN), Exelixis (NASDAQ:EXEL), Moderna (NASDAQ:MRNA), Exact Sciences Corp (NASDAQ:EXAS).

Industry description

Few industries pique investor interest like the high-risk, high-reward biotechnology sector. It is not unusual for a biotech company’s stock to soar in value following the development of a successful product...even if it is just as likely that tens of millions of dollars in research will lead to nothing substantial. Biotech companies earn headlines for developing lifesaving and (potentially) massively lucrative treatments for illness, but the industry’s scope extends beyond healthcare to food and agriculture, industrial processing, and more. Any company producing technology that incorporates biological organisms falls within the sector. The search for the next big thing in biotech may come with risk, but investors have reason for optimism. Biotech products like DNA sequencing and gene therapy are experiencing increased demand and decreasing prices, while rising populations around the world mean demand for food and agricultural products resistant to environmental factors. Biotech’s biggest names include multinational corporations like Johnson & Johnson, Amgen, and Roche, who each sport market capitalizations in the hundreds of billions of dollars. With new government rules opening China as a market for new treatments, the biotech sector holds significant growth potential – and corresponding profitability for investors.

Market Cap

The average market capitalization across the biotechnology Theme is 6.67B. The market cap for tickers in the group ranges from 658 to 180.28B. TMO holds the highest valuation in this group at 180.28B. The lowest valued company is MTEM at 658.

High and low price notable news

The average weekly price growth across all stocks in the biotechnology Theme was 5%. For the same Theme, the average monthly price growth was 6%, and the average quarterly price growth was 27%. BTAI experienced the highest price growth at 129%, while NCNA experienced the biggest fall at -45%.

Volume

The average weekly volume growth across all stocks in the biotechnology Theme was -10%. For the same stocks of the Theme, the average monthly volume growth was 132% and the average quarterly volume growth was 144%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 77
Price Growth Rating: 58
SMR Rating: 88
Profit Risk Rating: 90
Seasonality Score: -21 (-100 ... +100)

Market Cap

The average market capitalization across the group is 30.05M. The market cap for tickers in the group ranges from 22.79M to 37.31M. PLUR holds the highest valuation in this group at 37.31M. The lowest valued company is SNES at 22.79M.

High and low price notable news

The average weekly price growth across all stocks in the group was -11%. For the same group, the average monthly price growth was -9%, and the average quarterly price growth was 22%. PLUR experienced the highest price growth at -8%, while SNES experienced the biggest fall at -14%.

Volume

The average weekly volume growth across all stocks in the group was 229%. For the same stocks of the group, the average monthly volume growth was 80% and the average quarterly volume growth was 221%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 82
P/E Growth Rating: 100
Price Growth Rating: 53
SMR Rating: 99
Profit Risk Rating: 100
Seasonality Score: -25 (-100 ... +100)
VS
PLUR vs. SNES commentary
Aug 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLUR is a Hold and SNES is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 13, 2025
Stock price -- (PLUR: $4.74 vs. SNES: $4.59)
Brand notoriety: PLUR and SNES are both not notable
PLUR represents the Biotechnology, while SNES is part of the Chemicals: Specialty industry
Current volume relative to the 65-day Moving Average: PLUR: 32% vs. SNES: 40%
Market capitalization -- PLUR: $37.31M vs. SNES: $22.79M
PLUR [@Biotechnology] is valued at $37.31M. SNES’s [@Chemicals: Specialty] market capitalization is $22.79M. The market cap for tickers in the [@Biotechnology] industry ranges from $96.01B to $0. The market cap for tickers in the [@Chemicals: Specialty] industry ranges from $221.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.79B. The average market capitalization across the [@Chemicals: Specialty] industry is $8.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLUR’s FA Score shows that 0 FA rating(s) are green whileSNES’s FA Score has 0 green FA rating(s).

  • PLUR’s FA Score: 0 green, 5 red.
  • SNES’s FA Score: 0 green, 5 red.
According to our system of comparison, SNES is a better buy in the long-term than PLUR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLUR’s TA Score shows that 3 TA indicator(s) are bullish while SNES’s TA Score has 5 bullish TA indicator(s).

  • PLUR’s TA Score: 3 bullish, 5 bearish.
  • SNES’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SNES is a better buy in the short-term than PLUR.

Price Growth

PLUR (@Biotechnology) experienced а -8.14% price change this week, while SNES (@Chemicals: Specialty) price change was -14.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.20%. For the same industry, the average monthly price growth was +20.03%, and the average quarterly price growth was +19.94%.

The average weekly price growth across all stocks in the @Chemicals: Specialty industry was +6.65%. For the same industry, the average monthly price growth was +9.86%, and the average quarterly price growth was +6.99%.

Industries' Descriptions

@Biotechnology (+11.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Chemicals: Specialty (+6.65% weekly)

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLUR($37.3M) has a higher market cap than SNES($22.8M). SNES YTD gains are higher at: 38.671 vs. PLUR (10.877). SNES has higher annual earnings (EBITDA): -5.84M vs. PLUR (-20.22M). PLUR has more cash in the bank: 26.3M vs. SNES (1.66M). SNES has less debt than PLUR: SNES (248K) vs PLUR (31.2M). SNES has higher revenues than PLUR: SNES (1.93M) vs PLUR (1.03M).
PLURSNESPLUR / SNES
Capitalization37.3M22.8M164%
EBITDA-20.22M-5.84M346%
Gain YTD10.87738.67128%
P/E RatioN/A0.02-
Revenue1.03M1.93M54%
Total Cash26.3M1.66M1,589%
Total Debt31.2M248K12,581%
FUNDAMENTALS RATINGS
PLUR vs SNES: Fundamental Ratings
PLUR
SNES
OUTLOOK RATING
1..100
5366
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
66
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
6442
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNES's Valuation (66) in the Biotechnology industry is in the same range as PLUR (98). This means that SNES’s stock grew similarly to PLUR’s over the last 12 months.

SNES's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PLUR (100). This means that SNES’s stock grew similarly to PLUR’s over the last 12 months.

SNES's SMR Rating (99) in the Biotechnology industry is in the same range as PLUR (100). This means that SNES’s stock grew similarly to PLUR’s over the last 12 months.

SNES's Price Growth Rating (42) in the Biotechnology industry is in the same range as PLUR (64). This means that SNES’s stock grew similarly to PLUR’s over the last 12 months.

SNES's P/E Growth Rating (100) in the Biotechnology industry is in the same range as PLUR (100). This means that SNES’s stock grew similarly to PLUR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PLURSNES
RSI
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 14 days ago
77%
Bullish Trend 10 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
PLUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNES
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SLSN3.790.26
+7.37%
Solesence Inc
AEIS158.817.20
+4.75%
Advanced Energy Industries
CVAC5.470.04
+0.74%
CureVac NV
AIFF2.78N/A
N/A
Firefly Neuroscience Inc
BSX102.64-0.11
-0.11%
Boston Scientific Corp

PLUR and Stocks

Correlation & Price change

A.I.dvisor tells us that PLUR and KOD have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PLUR and KOD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLUR
1D Price
Change %
PLUR100%
+4.18%
KOD - PLUR
29%
Poorly correlated
+6.10%
RZLT - PLUR
28%
Poorly correlated
+4.38%
RLMD - PLUR
28%
Poorly correlated
+4.42%
BEAM - PLUR
25%
Poorly correlated
-1.78%
CSBR - PLUR
25%
Poorly correlated
+2.35%
More

SNES and Stocks

Correlation & Price change

A.I.dvisor tells us that SNES and MEOH have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNES and MEOH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNES
1D Price
Change %
SNES100%
+5.03%
MEOH - SNES
30%
Poorly correlated
+0.65%
DD - SNES
26%
Poorly correlated
+2.90%
GPRE - SNES
26%
Poorly correlated
-0.17%
REX - SNES
23%
Poorly correlated
+1.88%
FUL - SNES
23%
Poorly correlated
+3.34%
More